| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC | CMO,SVP,Head-Res&Drug | Class A Common Stock | 414K | $2.67M | $6.45 | May 20, 2024 | Direct |
| IRONWOOD PHARMACEUTICALS INC | CMO,SVP,Head-Res&Drug | Performance-based Restricted Stock Unit | 0 | $0 | $8.70 | Mar 8, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IRWD | IRONWOOD PHARMACEUTICALS INC | May 20, 2024 | 1 | -$104K | 4 | May 22, 2024 | CMO,SVP,Head-Res&Drug |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Mar 8, 2024 | 2 | $0 | 4 | Mar 12, 2024 | CMO,SVP,Head-Res&Drug |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Feb 12, 2024 | 3 | -$589K | 4 | Feb 14, 2024 | CMO,SVP,Head-Res&Drug |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Jan 17, 2024 | 1 | $0 | 4 | Jan 19, 2024 | CMO,SVP,Head-Res&Drug |
| IRWD | IRONWOOD PHARMACEUTICALS INC | May 22, 2023 | 1 | -$104K | 4 | May 24, 2023 | CMO,SVP,Head-Res&Drug |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Mar 8, 2023 | 2 | $0 | 4 | Mar 10, 2023 | CMO,SVP,Head-Res&Drug |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Feb 27, 2023 | 4 | -$219K | 4 | Mar 1, 2023 | CMO,SVP,Head-Res&Drug |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Jan 17, 2023 | 1 | $0 | 4 | Jan 19, 2023 | CMO,SVP,Head-Res&Drug |
| IRWD | IRONWOOD PHARMACEUTICALS INC | May 23, 2022 | 2 | -$122K | 4 | May 25, 2022 | CMO,SVP,Head-Res&Drug |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Mar 2, 2022 | 1 | $0 | 4 | Mar 4, 2022 | CMO,SVP,Head-Res&Drug |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Feb 28, 2022 | 5 | -$190K | 4 | Mar 2, 2022 | CMO,SVP,Head-Res&Drug |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Jan 19, 2022 | 1 | $0 | 4 | Jan 21, 2022 | CMO,SVP,Head-Res&Drug |
| IRWD | IRONWOOD PHARMACEUTICALS INC | Nov 23, 2021 | 1 | -$160K | 4 | Nov 24, 2021 | CMO,SVP,Head-Res&Drug |
| IRWD | IRONWOOD PHARMACEUTICALS INC | May 24, 2021 | 1 | -$25.4K | 4 | May 26, 2021 | CMO, SVP & Head of Drug Devt. |